Optune for Children With High-Grade Glioma or Ependymoma, and Optune With Radiation Therapy for Children With DIPG

Clinical trial NCT03033992 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT03033992
Sponsor: Children's Oncology Group
Status: ACTIVE_NOT_RECRUITING
Phase: Not Applicable
Study type: INTERVENTIONAL

Malignant Glioma Ependymoma Diffuse Intrinsic Pontine Glioma

Start date: 2017-04-04
Primary completion: 2032-07-22
Enrollment: 80

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.